Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biogen -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (540)	1/16/1998 12:04:00 PM
From: scaram(o)uche	Read Replies (2) \| Respond to of 1686

Yes, well, analysts rarely stand in front of a crowd and say "I'm sort of ambivalent on this company" as part of their introduction. If you base your buys on Rich's comments during introductions at the meeting, you'll have a diverse portfolio indeed. If he predicted last year that LGND would be the first profitable "targeted drug design" company, he was clearly wrong. He picked BGEN and GILD. No, I have not seen an electronic version, but I was there and I have the National Audio tape. What would you like to know? LGND was mentioned in passing with several other respected companies.